IMO: No buyout in the near future. Do your own DD and you will come to the same conclusion. Consider this folks: What value would you place on this company? Why would you sellout before launch when you have a trained sales force in place; done your market research; established your distribution channels; obtained sufficient funding for the initial launch; and refined your marketing/distribution plans? Also, why would you sellout before you exploit opportunities and established the value of Nuedexta for the DPN indication which may be greater than PBA? Finally, why would you sellout before you established the value of Nuedexta approval/sales for foreign Nuedexta PBA/off-label DPN indications? Keith may or may not be greedy but he has a plan and so far it appears he is executing to it.